Intellia Therapeutics, Inc. · 7 hours ago
Director, Launch Readiness Project Manager
Cambridge, MA
Full-time
Hybrid
Director/Executive
$218K/yr - $267K/yr
6+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Director, Launch Readiness Project Manager will oversee the planning and execution of commercial launch strategies, ensuring cross-functional collaboration and documentation management to support the company's first commercial launch.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Lead the development and management of the Integrated Launch Plan (ILP) in alignment with brand strategy
Lead Launch Readiness Reviews with Functional and Executive Leadership in partnership with Commercial and Program Leadership
Facilitate bi-weekly Launch Readiness Team meetings
Support planning of milestone meetings such as launch simulations, Day 0, Launch Training Meetings, National Sales Meetings
Work collaboratively across functions to identify and mitigate risks, develop scenario planning, to ensure teams stay on track
Develop and maintain comprehensive project documentation, including project plans, process flows, status reports, decision logs, project risks, and performance metrics
Manages Day 0 minute by minute schedule
Develop launch playbook and best practice documentation to accelerate future launches
Perform other duties as assigned
Qualification
Required
Bachelor's degree required
Minimum of 6 years of experience in project management within the pharmaceutical industry, with a focus on commercial operations and launch excellence
Proven track record of collaboration and coordination with key internal stakeholders, including the ability to influence without formal authority
Excellent verbal, written, and interpersonal skills with the ability to influence senior management and establish effective working relationships with a diverse range of stakeholders
Exceptional skills in proactivity, planning, prioritization, objective setting, meeting management, and plan execution
Organized and logical, with a high degree of flexibility to change direction when needed
A confident self-starter who can work independently and creatively, while also being a team player
Proficiency in Microsoft Office tools (Excel, Outlook, Word, PowerPoint, etc.) and in Smartsheets
Travels as needed: 20%
Lead the development and management of the Integrated Launch Plan (ILP) in alignment with brand strategy
Lead Launch Readiness Reviews with Functional and Executive Leadership in partnership with Commercial and Program Leadership
Facilitate bi-weekly Launch Readiness Team meetings
Support planning of milestone meetings such as launch simulations, Day 0, Launch Training Meetings, National Sales Meetings
Work collaboratively across functions to identify and mitigate risks, develop scenario planning, to ensure teams stay on track
Develop and maintain comprehensive project documentation, including project plans, process flows, status reports, decision logs, project risks, and performance metrics
Manages Day 0 minute by minute schedule
Develop launch playbook and best practice documentation to accelerate future launches
Perform other duties as assigned
Preferred
PMP certification preferred
Experience supporting the first launch of the company is highly desired
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
2025-12-29
EIN Presswire
2025-11-26
Company data provided by crunchbase